| Methodologies for surveying herpetofauna mortality on rural highways TA Langen, A Machniak, EK Crowe, C Mangan, DF Marker, N Liddle, ... The Journal of wildlife management 71 (4), 1361-1368, 2007 | 165 | 2007 |
| Human papillomavirus type 16 E6 and E 7 proteins alter NF-kB in cultured cervical epithelial cells and inhibition of NF-kB promotes cell growth and immortalization ER Vandermark, KA Deluca, CR Gardner, DF Marker, CN Schreiner, ... Virology 425 (1), 53-60, 2012 | 121 | 2012 |
| LRRK2 kinase inhibition prevents pathological microglial phagocytosis in response to HIV-1 Tat protein DF Marker, JM Puccini, TE Mockus, J Barbieri, SM Lu, HA Gelbard Journal of neuroinflammation 9, 1-12, 2012 | 98 | 2012 |
| Discovery, synthesis, and characterization of an orally bioavailable, brain penetrant inhibitor of mixed lineage kinase 3 VS Goodfellow, CJ Loweth, SB Ravula, T Wiemann, T Nguyen, Y Xu, ... Journal of medicinal chemistry 56 (20), 8032-8048, 2013 | 86 | 2013 |
| A thin-skull window technique for chronic two-photon in vivo imaging of murine microglia in models of neuroinflammation DF Marker, ME Tremblay, SM Lu, AK Majewska, HA Gelbard JoVE (Journal of Visualized Experiments), e2059, 2010 | 79 | 2010 |
| HIV-1 Tat-induced microgliosis and synaptic damage via interactions between peripheral and central myeloid cells SM Lu, MÈ Tremblay, IL King, J Qi, HM Reynolds, DF Marker, JJP Varrone, ... PloS one 6 (9), e23915, 2011 | 78 | 2011 |
| The new small-molecule mixed-lineage kinase 3 inhibitor URMC-099 is neuroprotective and anti-inflammatory in models of human immunodeficiency virus-associated neurocognitive … DF Marker, MÈ Tremblay, JM Puccini, J Barbieri, MAG Marker, CJ Loweth, ... Journal of Neuroscience 33 (24), 9998-10010, 2013 | 76 | 2013 |
| Leucine-rich repeat kinase 2 modulates neuroinflammation and neurotoxicity in models of human immunodeficiency virus 1-associated neurocognitive disorders JM Puccini, DF Marker, T Fitzgerald, J Barbieri, CS Kim, P Miller-Rhodes, ... Journal of Neuroscience 35 (13), 5271-5283, 2015 | 63 | 2015 |
| Ultrastructure of microglia-synapse interactions in the HIV-1 Tat-injected murine central nervous system MÈ Tremblay, DF Marker, JM Puccini, EC Muly, SM Lu, HA Gelbard Communicative & Integrative Biology 6 (6), e27670, 2013 | 32 | 2013 |
| Homozygous deletion of CDKN2A by fluorescence in situ hybridization is prognostic in grade 4, but not grade 2 or 3, IDH-mutant astrocytomas DF Marker, TM Pearce Acta Neuropathologica Communications 8, 1-12, 2020 | 25 | 2020 |
| HIV Tat causes synapse loss in a mouse model of HIV‐associated neurocognitive disorder that is independent of the classical complement cascade component C1q JW Hammond, WQ Qiu, DF Marker, JM Chamberlain, W Greaves‐Tunnell, ... Glia 66 (12), 2563-2574, 2018 | 17 | 2018 |
| The mixed-lineage kinase inhibitor URMC-099 protects hippocampal synapses in experimental autoimmune encephalomyelitis MJ Bellizzi, JW Hammond, H Li, MAG Marker, DF Marker, RS Freeman, ... eneuro 5 (6), 2018 | 12 | 2018 |
| DNA methylation analysis of glioblastomas harboring FGFR3-TACC3 fusions identifies a methylation subclass with better patient survival Z Wu, O Lopes Abath Neto, TA Bale, J Benhamida, D Mata, R Turakulov, ... Acta neuropathologica 144 (1), 155-157, 2022 | 11 | 2022 |
| The dominant TP53 hotspot mutation in IDH-mutant astrocytoma, R273C, has distinctive pathologic features and sex-specific prognostic implications DF Marker, S Agnihotri, N Amankulor, GH Murdoch, TM Pearce Neuro-Oncology Advances 4 (1), vdab182, 2022 | 8 | 2022 |
| Multifocal necrotizing leukoencephalopathy with preferential microglia toxicity in a patient treated with chimeric antigen receptor T-cells and review of the literature DF Marker, JK Kofler, JA Mettenburg, ME Agha, CA Wiley Journal of Neuropathology & Experimental Neurology 79 (10), 1115-1121, 2020 | 7 | 2020 |
| Broad spectrum mixed lineage kinase type 3 inhibition and HIV-1 persistence in macrophages P Saminathan, BD Kevadiya, DF Marker, HE Gendelman, S Gorantla, ... Journal of Neuroimmune Pharmacology 14, 44-51, 2019 | 7 | 2019 |
| Germ cell tumors of the central nervous system: a brief review and site-specific considerations DF Marker, TM Pearce Seminars in Diagnostic Pathology 40 (1), 47-51, 2023 | 5 | 2023 |
| Soft tissue fibroblastic reticular cell tumor with whole-exome sequencing findings: an unexpected presentation of lynch syndrome LV Lopez, DF Marker, N Bailey, YC Liu, RL McGough, AD Singhi, I John AJSP: Reviews & Reports 24 (6), 288-291, 2019 | 4 | 2019 |
| Expanding the molecular signatures of malignant ossifying fibromyxoid tumours with two novel gene fusions: PHF1::FOXR1 and PHF1::FOXR2 P Srivastava, ML Zilla, R Naous, D Marker, P Khoshnoodi, M Burgess, ... Histopathology 82 (6), 946-952, 2023 | 3 | 2023 |
| Cervical intramedullary spinal cavernoma in setting of unresolved myelopathy: A case report E Nwachuku, J Duehr, S Kulich, D Marker, J Moossy Surgical Neurology International 11, 2020 | 3 | 2020 |
